Huntington's disease: a clinical review

被引:646
|
作者
Roos, Raymund A. C. [1 ]
机构
[1] LUMC, Dept Neurol, NL-2300 RC Leiden, Netherlands
来源
关键词
GENE CARRIERS; REPEAT; MODELS;
D O I
10.1186/1750-1172-5-40
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Huntington disease (HD) is a rare neurodegenerative disorder of the central nervous system characterized by unwanted choreatic movements, behavioral and psychiatric disturbances and dementia. Prevalence in the Caucasian population is estimated at 1/10,000-1/20,000. Mean age at onset of symptoms is 30-50 years. In some cases symptoms start before the age of 20 years with behavior disturbances and learning difficulties at school (Juvenile Huntington's disease; JHD). The classic sign is chorea that gradually spreads to all muscles. All psychomotor processes become severely retarded. Patients experience psychiatric symptoms and cognitive decline. HD is an autosomal dominant inherited disease caused by an elongated CAG repeat (36 repeats or more) on the short arm of chromosome 4p16.3 in the Huntingtine gene. The longer the CAG repeat, the earlier the onset of disease. In cases of JHD the repeat often exceeds 55. Diagnosis is based on clinical symptoms and signs in an individual with a parent with proven HD, and is confirmed by DNA determination. Pre-manifest diagnosis should only be performed by multidisciplinary teams in healthy at-risk adult individuals who want to know whether they carry the mutation or not. Differential diagnoses include other causes of chorea including general internal disorders or iatrogenic disorders. Phenocopies (clinically diagnosed cases of HD without the genetic mutation) are observed. Prenatal diagnosis is possible by chorionic villus sampling or amniocentesis. Preimplantation diagnosis with in vitro fertilization is offered in several countries. There is no cure. Management should be multidisciplinary and is based on treating symptoms with a view to improving quality of life. Chorea is treated with dopamine receptor blocking or depleting agents. Medication and non-medical care for depression and aggressive behavior may be required. The progression of the disease leads to a complete dependency in daily life, which results in patients requiring full-time care, and finally death. The most common cause of death is pneumonia, followed by suicide.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Early clinical markers of Huntington's disease
    Aylward, EH
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [32] Psychopathology of Huntington's disease:: Clinical summary
    Anders, M
    Roth, J
    Uhrová, T
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2003, 66 (04) : 247 - 250
  • [33] ATYPICAL CLINICAL PHENOTYPES OF HUNTINGTON'S DISEASE
    Power, Rachael
    Gall, Claire
    Nixon, John
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A38 - A38
  • [34] A review of the treatment options for Huntington's disease
    Bonelli, RM
    Hofmann, P
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (04) : 767 - 776
  • [35] Therapeutics for huntington's disease: A systematic review
    Mestre, T.
    Ferreira, J.
    Coelho, M.
    Rosa, M. M.
    Sampaio, C.
    MOVEMENT DISORDERS, 2007, 22 : S30 - S30
  • [36] Huntington's disease-like 2: a clinical, pathological, and molecular comparison to Huntington's disease
    Margolis, RL
    Holmes, SE
    CLINICAL NEUROSCIENCE RESEARCH, 2003, 3 (03) : 187 - 196
  • [37] Therapeutics for Huntington's disease: a systematic review
    Mestre, T. A.
    Ferreira, J. J.
    Coelho, M.
    Rosa, M. M.
    Sampaio, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 98 - 98
  • [38] Antidepressants for neuroprotection in Huntington's disease: A review
    Jamwal, Sumit
    Kumar, Puneet
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 769 : 33 - 42
  • [39] Clinical Presentation and Features of Juvenile-Onset Huntington's Disease: A Systematic Review
    Cronin, Thomas
    Rosser, Anne
    Massey, Thomas
    JOURNAL OF HUNTINGTONS DISEASE, 2019, 8 (02) : 171 - 179
  • [40] Huntington?s disease influences employment before and during clinical manifestation: A systematic review
    Van der Zwaan, Kasper F.
    Mentink, Marit D. C.
    Jacobs, Milou
    Roos, Raymund A. C.
    De Bot, Susanne T.
    PARKINSONISM & RELATED DISORDERS, 2022, 96 : 100 - 108